Glaukos (GKOS) Income from Continuing Operations (2014 - 2026)

Glaukos' (GKOS) quarterly Income from Continuing Operations came in at 19799000.0 in Q1 2026, down 9.11% year-on-year from 21783341.66 in Q1 2025, and up 85.76% on a QoQ basis from 139008000.0 in Q4 2025.

Glaukos (GKOS) Income from Continuing Operations (2014 - 2026) Analysis & Trends

Glaukos (GKOS) has 13 years of Income from Continuing Operations data on file, last reported at 19799000.0 in Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 9.11% year-over-year to 19799000.0 in Q1 2026; TTM through Mar 2026 was 194695000.0, a 57.46% decrease from a year earlier, with the FY2025 full-year figure at 193042000.0, down 31.88% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 19799000.0, up from 139008000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for GKOS reached as high as 5403000.0 in Q1 2022 and fell as low as 139008000.0 in Q4 2025.
  • Historically, Income from Continuing Operations has averaged 35048823.53 across 5 years, with a median of 32812000.0 in 2023.
  • Across the five-year window, Income from Continuing Operations soared 132.81% in 2022 and slumped 740.87% in 2023, its largest moves.
  • Year by year, Income from Continuing Operations stood at 34347000.0 in 2022, then decreased by 7.0% to 36752000.0 in 2023, then grew by 8.63% to 33580000.0 in 2024, then sank by 313.96% to 139008000.0 in 2025, then surged by 85.76% to 19799000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 19799000.0 in Q1 2026, 139008000.0 in Q4 2025, and 16231000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Glaukos 8.83 Bn 8.73 Bn 117.23 Mn -19.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.80 Mn
Dec 31, 2025 -139.01 Mn
Sep 30, 2025 -16.23 Mn
Jun 30, 2025 -19.66 Mn
Mar 31, 2025 -18.15 Mn
Dec 31, 2024 -33.58 Mn
Sep 30, 2024 -21.41 Mn
Jun 30, 2024 -50.51 Mn
Mar 31, 2024 -40.84 Mn
Dec 31, 2023 -36.75 Mn
Sep 30, 2023 -30.44 Mn
Jun 30, 2023 -32.81 Mn
Mar 31, 2023 -34.63 Mn
Dec 31, 2022 -34.35 Mn
Sep 30, 2022 -27.53 Mn
Jun 30, 2022 -45.54 Mn
Mar 31, 2022 5.40 Mn
Dec 31, 2021 -21.87 Mn
Sep 30, 2021 6.23 Mn
Jun 30, 2021 -17.48 Mn